TMCnet News
Luminex Corporation Receives FDA Clearance and CE Mark for SYNCT SoftwareAUSTIN, Texas, April 14, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that its SYNCT™ Software has received both U.S. Food and Drug Administration (FDA) clearance and CE Marking for use with its ARIES® System and NxTAG® assays on the MAGPIX® System. SYNCT Software is middleware that provides access to data and reports through a single interface, and allows for customizable workflows by connecting ARIES® and NxTAG-enabled MAGPIX workstations in the lab. Specifically designed for molecular laboratories running ARIES® and NxTAG assays, SYNCT empowers laboratory directors by offering a streamlined workflow, enhanced data management, and the ability to easily add new functionality. From anywhere in the lab, users can create and prepare orders or manage results from all next-generation Luminex instruments, allowing for division of labor and flexibility to work within any lab process connected to SYNCT. Centralized reporting allows for higher-quality results because data can be accumulated in one place and overseen by the laboratory director. Labs with multiple locations can use SYNCT Software to route all results to a single reviewer, anywhere on the lab network, before sending to the lab information system. "SYNCT is efficient software for our daily workflow," said Tong Her, Medical Laboratory Scientist, Test Development and Validation, St. John Hospital and Medical Center. "The order management menu makes it easy to order tests and the 'run report' tool allows for simple interpretation of test results." Optional applications that provide more functionality and value can easily be added with minimal validation effort. As an example, the ARIES® UDP (User Defined Protocol) App enables customers to create assay protocol files for running analyte specific reagents or customer developed primers in laboratory developed tests. "Challenges associated with software and information systems that don't talk to each other waste precious time that lab directors would rather spend maximizing efficiency and ensuring the most accurate and reproducible results from their lab," said Eric Shapiro, Vice President, Global Marketing at Luminex Corporation. "We are proud to offer our molecular lab customers a better way to manage their data while reducing operational costs." About the ARIES® System About NxTAG About Luminex Corporation Statements made in this release that express Luminex's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements. Forward-looking statements in this release include statements regarding the development and testing progress of our pipeline products, and the regulatory approvals thereof. The words "believe", "expect", "intend", "anticipates", "confident", "will", "could", "should", and similar expressions are intended to further identify such forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. It is important to note that the Company's actual results or performance could differ materially from those anticipated in such forward-looking statements. Factors that could cause Luminex's actual results or performance to differ materially include risks and uncertainties relating to, among others, our ability to launch products on time, the timing of regulatory approvals, the outcome of clinical trials as well as the risks discussed under the heading "Risk Factors" in Luminex's Reports on Forms 10-K and 10-Q, as filed with the Securities and Exchange Commission. The forward looking statements contained herein represent the judgment of Luminex as of the date of this press release, and Luminex expressly disclaims any intent, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in Luminex's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. Contacts Luminex Media Contact Logo - http://photos.prnewswire.com/prnh/20150201/172702LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/luminex-corporation-receives-fda-clearance-and-ce-mark-for-synct-software-300251320.html SOURCE Luminex Corporation |